Ridvan Arda Demirci

SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617

Journal of Nuclear Medicine · 2024 · First of 12 authors · 19 citations

PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG-Avid…

Journal of Nuclear Medicine · 2025 · First of 14 authors · 14 citations